Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug‐disease modelling for dosing regimen optimization

AIM: Pharmacologic effects were analysed to determine a dose recommendation for oseltamivir in immunocompromised (IC) adults with influenza. METHODS: Quantitative clinical pharmacology methods were applied to data from 160 adult IC patients (aged 18‐78 years) from two studies (NV20234, 150 patients;...

Descripción completa

Detalles Bibliográficos
Autores principales: Sturm, Stefan, Lemenuel‐Diot, Annabelle, Patel, Kashyap, Gibiansky, Leonid, Bhardwaj, Rajinder, Smith, Patrick F., Dang, Steve, Zwanziger, Elke, Nasmyth‐Miller, Clare, Ravva, Patanjali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246794/
https://www.ncbi.nlm.nih.gov/pubmed/32808306
http://dx.doi.org/10.1111/bcp.14523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246794/
https://www.ncbi.nlm.nih.gov/pubmed/32808306
http://dx.doi.org/10.1111/bcp.14523

Ejemplares similares